TABLE 14: Treatment - chemotherapy

% of Cases treated with Chemotherapy
Country average (population) Country average (country) England Scotland Northern Ireland Wales
All invasive xnmsc 25.6% 25.0% 25.9% 22.0% 25.5% 26.8%
All xnmsc 0-24 64.9% 59.5% 66.1% 59.8% 53.7% 58.1%
All xnmsc 25-59 40.5% 41.6% 40.2% 39.8% 41.4% 45.0%
All xnmsc 60-79 26.0% 25.1% 26.5% 21.0% 25.4% 27.4%
All xnmsc 80+ 7.8% 6.4% 8.2% 4.4% 6.0% 7.1%
Haematology 52.2% 49.6% 52.6% 50.7% 43.9% 51.2%
Head and Neck 28.7% 26.7% 29.3% 23.5% 20.6% 33.4%
Lower GI 30.8% 31.2% 31.0% 26.3% 34.2% 33.3%
Upper GI 38.2% 38.0% 38.5% 34.0% 40.3% 39.1%
HPB 23.4% 21.2% 24.2% 16.6% 23.4% 20.8%
Trachea, Bronchus & Lung 22.4% 22.0% 23.1% 15.0% 24.2% 25.7%
Melanoma of skin 3.8% 3.9% 3.9% 0.5% 4.0% 7.4%
Breast 32.5% 32.6% 32.4% 31.7% 31.8% 34.5%
Cervix 39.6% 41.5% 38.9% 44.7% 42.5% 40.0%
Other Female Genitals 29.2% 27.3% 29.5% 29.5% 24.5% 25.5%
Prostate 5.6% 6.2% 5.6% 2.2% 8.2% 8.9%
Kidney 9.3% 10.8% 9.3% 4.2% 12.8% 16.7%
Bladder 26.6% 27.5% 26.7% 22.6% 28.9% 31.7%
Brain and CNS 35.0% 32.1% 35.5% 35.3% 28.2% 29.6%
Thyroid & other endocrine glands 3.4% 7.3% 2.9% 4.4% 3.8% 18.2%
CUP 7.9% 9.3% 7.9% 8.8% 15.5% 5.2%
Other invasive cancer 26.5% 26.1% 26.6% 24.7% 26.7% 26.4%
Breast in situ 1.7% 1.8% 1.7% 0.3% 4.6% 0.4%
Cervix in situ 0.0% 0.1% 0.0% 0.0% 0.3% 0.0%
Other tumours 12.2% 10.2% 12.5% 14.1% 4.4% 9.9%
Non-Melanoma Skin Cancer 0.2% 0.5% 0.1% 0.9% 1.0% 0.1%